High-dose chemotherapy and stem cell transplantation for primary CNS lymphoma

Carole Soussain, Patrick Bruce Johnston, Gerald Illerhaus

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The treatment of patients with CNS lymphoma has posed a challenge since this entity was first described. Several issues have complicated the management of these patients. First, it is important to define whether the lymphoma is confined to the CNS (primary CNS lymphoma, PCNSL) or whether there is co-existent or pre-existent systemic lymphoma (stage IV or secondary CNS lymphoma, respectively). Second, it is important to define the histological subtypes of lymphoma involving the CNS since multiple histologies are known to occur in the CNS and the treatment can vary depending on the histology.

Original languageEnglish (US)
Title of host publicationLymphoma and Leukemia of the Nervous System
PublisherSpringer New York
Pages155-168
Number of pages14
ISBN (Print)9781441976680, 9781441976673
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'High-dose chemotherapy and stem cell transplantation for primary CNS lymphoma'. Together they form a unique fingerprint.

  • Cite this

    Soussain, C., Johnston, P. B., & Illerhaus, G. (2012). High-dose chemotherapy and stem cell transplantation for primary CNS lymphoma. In Lymphoma and Leukemia of the Nervous System (pp. 155-168). Springer New York. https://doi.org/10.1007/9781441976680_9